Generic Drug Alert: FDA Approves Generic Version of Alzheimer’s Drug Razadyne

Quick generic drug approval bulletin for today. If you have a family member or other loved suffers from Alzheimer’s Disease, the U.S. Food and Drug Administration has given Aurobindo Pharmaceuticals final approval for galantamine tablets, a generic version of Ortho-McNeil’s prescription drug Razadyne which treats Alzheimer’s patients for mild to moderate dementia. According to the Alzheimer’s Association, Alzheimer’s is a brain disease that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time, becoming severe enough to interfere with daily tasks.

Considering a thirty-day supply of brand-name Razadyne is currently running about $205, generic galantamine tablets could easily be a major savings for the families of many Alzheimer’s Disease patients, so if someone in your family suffers from Alzheimer’s Disease,and is on Razadyne, you should ask their doctor if they are an appropriate candidate for the Razadyne generic counterpart.

Does someone in your family use Razadyne? Tell us about it!

Related posts:

1. Generic Drug Alert: FDA Approves Generic Version of Precose for Type 2 Diabetes
2. Generic Drug Alert: FDA Approves Generic Version of Epilepsy Drug Neurontin
3. Generic Drug Alert: FDA Approves Release of Generic Version of Protonix (Pantoprazole)
4. Generic Drug Alert: FDA Approves Generic Version of Lithobid
5. Generic Drug Alert: FDA Approves Generic Version of Lovenox Blood-Thinner